Literature DB >> 15913852

Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.

R Paillot1, J M Daly, V Juillard, J M Minke, D Hannant, J H Kydd.   

Abstract

Equine cytotoxic T lymphocyte (CTL) responses to equine herpesvirus-1 (EHV-1) are well characterised but little is known about the cytokine response after infection or vaccination. EHV-1 is common in horses and infects lymphocytes in vivo. This virus was used as a model to measure the synthesis of interferon gamma (IFN-gamma) by equine peripheral blood mononuclear cells (PBMC) after in vivo infection and/or in vitro stimulation with EHV-1. Both flow cytometry and ELISPOT assays were used to quantify equine IFN-gamma using a mouse anti-bovine IFN-gamma monoclonal antibody (clone CC302; shown to cross-react with recombinant equine IFN-gamma) and a rabbit anti-canine IFN-gamma polyclonal antibody. The percentage of PBMC synthesising IFN-gamma after in vitro stimulation with EHV-1 increased with age. In yearlings infected experimentally with EHV-1, PBMC showed two peaks of IFN-gamma synthesis, 11 and 56 days after infection. The IFN-gamma synthesis was principally associated with CD8(+) cells. The patterns of IFN-gamma synthesis detected by intracellular IFN-gamma staining or ELISPOT were compared with CTL data and shown to be similar. These methods were also applied successfully to frozen samples of PBMC. Measurement of equine IFN-gamma using these simple techniques can now be applied to future studies on protective cellular immune responses following virus infection and/or vaccination of horses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913852     DOI: 10.1016/j.vaccine.2005.03.048

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.

Authors:  Christiane L Schnabel; Susanna Babasyan; Alicia Rollins; Heather Freer; Christine L Wimer; Gillian A Perkins; Fahad Raza; Nikolaus Osterrieder; Bettina Wagner
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  Immunological correlates of vaccination and infection for equine herpesvirus 1.

Authors:  Laura B Goodman; Christine Wimer; Edward J Dubovi; Carvel Gold; Bettina Wagner
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

3.  Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model.

Authors:  Bart Spiesschaert; Björn Goldenbogen; Selina Taferner; Matthias Schade; Medhat Mahmoud; Edda Klipp; Nikolaus Osterrieder; Walid Azab
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

4.  Swine virus-specific cytotoxic cells producing IFNgamma under different conditions of virus antigenic stimulation.

Authors:  L Ferrari; E De Angelis; P Martelli; P Borghetti
Journal:  Vet Res Commun       Date:  2010-06       Impact factor: 2.459

5.  Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity.

Authors:  Romain Paillot; Carl Robinson; Karen Steward; Nicola Wright; Thibaud Jourdan; Nicola Butcher; Zoe Heather; Andrew S Waller
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

6.  Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals.

Authors:  Bettina Wagner; Alexandra Burton; Dorothy Ainsworth
Journal:  Vet Res       Date:  2010-04-09       Impact factor: 3.683

7.  Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.

Authors:  Robert H Mealey; Matt H Littke; Steven R Leib; William C Davis; Travis C McGuire
Journal:  Vet Immunol Immunopathol       Date:  2007-04-08       Impact factor: 2.046

8.  Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.

Authors:  Gisela Soboll Hussey; Stephen B Hussey; Bettina Wagner; David W Horohov; Gerlinde R Van de Walle; Nikolaus Osterrieder; Lutz S Goehring; Sangeeta Rao; David P Lunn
Journal:  Vet Res       Date:  2011-02-07       Impact factor: 3.683

9.  Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment.

Authors:  Erika S Hue; Eric A Richard; Christine I Fortier; Guillaume D Fortier; Romain Paillot; Rudiger Raue; Stéphane L Pronost
Journal:  Vaccines (Basel)       Date:  2017-09-19

10.  The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.

Authors:  Christine L Wimer; Christiane L Schnabel; Gillian Perkins; Susanna Babasyan; Heather Freer; Alison E Stout; Alicia Rollins; Nikolaus Osterrieder; Laura B Goodman; Amy Glaser; Bettina Wagner
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.